Table 3.
Descriptive of intervention outcomes at preintervention, postintervention, and follow-up scheduled assessment time points by preintervention clinical diagnostic presentation subgroups.
|
|
Preintervention: week 0 (n=241) | Postintervention: week 8 (n=58-61) | 1-month follow-up: week 12 (n=41) | 3-month follow-up: week 20 (n=34-35) | ||||||||||||||||
|
|
Values, n (%) | Values, mean (SD) | Values, n (%) | Values, mean (SD) | Values, n (%) | Values, mean (SD) | Values, n (%) | Values, mean (SD) | ||||||||||||
| GAD-7a | ||||||||||||||||||||
|
|
Anxiety | 26 (10.8) | 12.35 (3.53) | 9 (14.8) | 4.78 (2.33) | 7 (17.1) | 5.86 (1.86) | 5 (14.3) | 4.40 (2.70) | |||||||||||
|
|
Depression | 23 (9.5) | 5.43 (1.67) | 6 (9.8) | 4.00 (4.77) | 5 (12.2) | 3.20 (2.59) | 5 (14.3) | 3.60 (2.88) | |||||||||||
|
|
Comorbid | 136 (56.4) | 15.03 (4.13) | 34 (55.7) | 6.56 (6.08) | 24 (58.5) | 6.88 (6.15) | 19 (54.3) | 6.26 (5.88) | |||||||||||
|
|
Nonclinical | 56 (23.2) | 5.05 (1.86) | 12 (19.7) | 4.58 (2.43) | 5 (12.2) | 6.00 (3.54) | 6 (17.1) | 3.67 (3.72) | |||||||||||
| PHQ-9b | ||||||||||||||||||||
|
|
Anxiety | 26 (10.8) | 6.81 (2.25) | 9 (15) | 3.89 (3.52) | 7 (17.1) | 3.29 (2.50) | 5 (14.7) | 3.00 (2.35) | |||||||||||
|
|
Depression | 26 (10.8) | 12.91 (3.26) | 6 (10) | 6.83 (8.73) | 5 (12.2) | 6.40 (6.54) | 5 (14.7) | 6.80 (6.98) | |||||||||||
|
|
Comorbid | 136 (56.4) | 17.37 (4.94) | 33 (55) | 8.33 (7.43) | 24 (58.5) | 8.79 (7.37) | 19 (55.9) | 8.00 (6.76) | |||||||||||
|
|
Nonclinical | 56 (23.2) | 5.05 (2.54) | 12 (20) | 4.17 (2.52) | 5 (12.2) | 6.40 (3.21) | 5 (14.7) | 6.60 (5.41) | |||||||||||
| K-6c | ||||||||||||||||||||
|
|
Anxiety | 26 (10.8) | 12.92 (2.87) | 9 (15) | 9.78 (1.56) | 7 (17.1) | 10.00 (0.82) | 5 (14.7) | 8.40 (1.67) | |||||||||||
|
|
Depression | 23 (9.5) | 15.04 (3.57) | 6 (10) | 11.83 (6.62) | 5 (12.2) | 12.00 (5.29) | 5 (14.7) | 12.20 (7.82) | |||||||||||
|
|
Comorbid | 136 (56.4) | 20.53 (4.73) | 33 (55) | 13.24 (6.49) | 24 (58.5) | 11.92 (5.77) | 19 (55.9) | 11.21 (4.89) | |||||||||||
|
|
Nonclinical | 56 (23.2) | 10.63 (2.73) | 12 (20) | 10.75 (2.56) | 5 (12.2) | 12.60 (5.22) | 5 (14.7) | 11.60 (5.03) | |||||||||||
| DERS-36d | ||||||||||||||||||||
|
|
Anxiety | 26 (10.8) | 95.88 (19.37) | 9 (15.3) | 79.00 (21.43) | 7 (17.1) | 73.71 (20.34) | 5 (14.7) | 70.00 (23.77) | |||||||||||
|
|
Depression | 23 (9.5) | 92.04 (20.76) | 6 (10.2) | 70.17 (36.68) | 5 (12.2) | 81.80 (22.58) | 5 (14.7) | 74.00 (28.30) | |||||||||||
|
|
Comorbid | 136 (56.4) | 114.21 (21.49) | 32 (54.2) | 85.63 (33.74) | 24 (58.5) | 81.04 (33.44) | 19 (55.9) | 74.79 (29.51) | |||||||||||
|
|
Nonclinical | 56 (23.2) | 83.93 (23.07) | 12 (20.3) | 77.42 (21.38) | 5 (12.2) | 65.40 (16.56) | 5 (14.7) | 71.00 (7.97) | |||||||||||
| MHC-SFe | ||||||||||||||||||||
|
|
Anxiety | 26 (10.8) | 38.42 (11.93) | 9 (15) | 44.44 (10.69) | 7 (17.1) | 51.57 (10.21) | 5 (14.7) | 47.80 (13.29) | |||||||||||
|
|
Depression | 23 (9.5) | 27.83 (11.01) | 6 (10) | 46.00 (21.42) | 5 (12.2) | 40.60 (18.81) | 5 (14.7) | 43.80 (17.12) | |||||||||||
|
|
Comorbid | 136 (56.4) | 24.93 (12.14) | 33 (55) | 42.36 (20.02) | 24 (58.5) | 46.08 (17.43) | 19 (55.9) | 43.89 (19.64) | |||||||||||
|
|
Nonclinical | 56 (23.2) | 41.95 (12.22) | 12 (20) | 46.17 (10.99) | 5 (12.2) | 36.40 (20.07) | 5 (14.7) | 32.80 (7.79) | |||||||||||
| R-LOTf | ||||||||||||||||||||
|
|
Anxiety | 26 (10.8) | 13.08 (4.99) | 9 (15.3) | 16.78 (4.27) | 7 (17.1) | 19.57 (3.05) | 5 (14.7) | 19.00 (5.39) | |||||||||||
|
|
Depression | 23 (9.5) | 12.09 (3.60) | 6 (10.2) | 15.17 (5.88) | 5 (12.2) | 14.80 (3.96) | 5 (14.7) | 12.60 (4.98) | |||||||||||
|
|
Comorbid | 136 (56.4) | 10.01 (4.99) | 32 (54.2) | 14.81 (6.76) | 24 (58.5) | 15.33 (6.15) | 19 (55.9) | 15.16 (5.01) | |||||||||||
|
|
Nonclinical | 56 (23.2) | 13.71 (4.63) | 12 (20.3) | 14.83 (4.61) | 5 (12.2) | 15.40 (5.03) | 5 (14.7) | 15.40 (3.91) | |||||||||||
| ED-5D-3L Utility Index | ||||||||||||||||||||
|
|
Anxiety | 26 (10.8) | 0.77 (0.11) | 9 (15.5) | 0.88 (0.11) | 7 (17.1) | 0.79 (0.19) | 5 (14.7) | 0.86 (0.08) | |||||||||||
|
|
Depression | 23 (9.5) | 0.75 (0.11) | 6 (10.3) | 0.77 (0.23) | 5 (12.2) | 0.87 (0.13) | 5 (14.7) | 0.74 (0.31) | |||||||||||
|
|
Comorbid | 136 (56.4) | 0.61 (0.19) | 31 (53.4) | 0.77 (0.23) | 24 (58.5) | 0.81 (0.17) | 19 (55.9) | 0.79 (0.19) | |||||||||||
|
|
Nonclinical | 56 (23.2) | 0.86 (0.14) | 12 (20.7) | 0.90 (0.11) | 5 (12.2) | 0.87 (0.12) | 5 (14.7) | 0.85 (0.23) | |||||||||||
| ED-5D-3L Health Rating | ||||||||||||||||||||
|
|
Anxiety | 26 (10.8) | 71.46 (10.89) | 9 (15.5) | 78.33 (10.31) | 7 (17.1) | 71.14 (28.82) | 5 (14.7) | 81.60 (11.63) | |||||||||||
|
|
Depression | 23 (9.5) | 60.70 (16.16) | 6 (10.3) | 79.17 (18.28) | 5 (12.2) | 80.60 (11.15) | 5 (14.7) | 57.00 (34.74) | |||||||||||
|
|
Comorbid | 136 (56.4) | 54.86 (21.41) | 31 (53.4) | 69.29 (23.46) | 24 (58.5) | 67.50 (24.16) | 19 (55.9) | 74.53 (17.11) | |||||||||||
|
|
Nonclinical | 56 (23.2) | 75.55 (12.69) | 12 (20.7) | 78.75 (14.60) | 5 (12.2) | 62.80 (34.41) | 5 (14.7) | 76.40 (5.46) | |||||||||||
aGAD-7: Generalized Anxiety Disorder 7.
bPHQ-9: Patient Health Questionnaire 9
cK-6: Kessler 6.
dDERS-36: Difficulties in Emotional Regulation 36.
eMHC-SF: Mental Health Continuum—Short Form.
fR-LOT: Revised Life Orientation Test.